IMPACT OF FIXED-DOSE 4F-PCC ON TIME TO ADMINISTRATION FOR ANTICOAGULATION REVERSAL IN THE ED

被引：0
|
作者：
DeFilippo, Nicholas [1 ]
Jones, Kerri [1 ]
Pournezhad, Sam [2 ]
Patka, John [1 ]
Chester, Katleen [2 ]
Morrison, Christopher [1 ]
机构：
[1] Grady Mem Hosp, Atlanta, GA USA
[2] Grady Hlth Syst, Emeryville, CA USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1007
引用
收藏
页码：497 / 497
页数：1
相关论文
共 50 条
  • [41] INR and vitamin K-dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasma
    Hood, Christopher
    Goldstein, Joshua N.
    Milling, Truman J.
    Refaai, Majed A.
    Bajcic, Paolo
    Goldstein, Brahm
    Sarode, Ravi
    BLOOD ADVANCES, 2023, 7 (10) : 2206 - 2213
  • [42] Impact of Obesity on Warfarin Reversal With Fixed-Dose Factor VIII Inhibitor Bypassing Activity (aPCC)
    McKinney, Amanda L.
    Dailey, Lindsey M.
    McMillen, James C.
    Rowe, A. Shaun
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (07) : 856 - 862
  • [43] REDUCED TIME TO GASTROINTESTINAL PROCEDURE AFTER WARFARIN REVERSAL WITH FOUR FACTOR PROTHROMBIN COMPLEX CONCENTRATE (4F-PCC) AS COMPARED TO PLASMA IN PATIENTS WITH GASTROINTESTINAL BLEEDING
    McRae, Hannah L.
    Spector, Hannah
    Love, Tanzy
    Sturpe, Deborah
    Northam, Kalynn
    Refaai, Majed A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E72 - E72
  • [44] Evaluation of a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal
    McMahon, Clare
    Halfpap, Joe
    Zhao, Qianqian
    Bienvenida, Ana
    Rose, Anne E.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (10) : 1230 - 1235
  • [45] TIME TO 4F-PCC AND BLOOD PRESSURE CONTROL IN FACTOR XA INHIBITOR-ASSOCIATED INTRACEREBRAL HEMORRHAGE
    Vilar, Jason
    Priano, James
    Rzasa, Kaitlin
    CRITICAL CARE MEDICINE, 2020, 48
  • [46] FIXED-DOSE 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE ADMINISTRATION: IN SEARCH OF THE OPTIMAL DOSING
    Mishra, Ajay Kumar
    Sahu, Kamal Kant
    John, Kevin
    Lal, Amos
    JOURNAL OF EMERGENCY MEDICINE, 2020, 59 (02): : 313 - 314
  • [47] COMPARISON OF FIXED-DOSE AND WEIGHT-BASED 4-FACTOR PCC TO REVERSE WARFARIN-ASSOCIATED HEMORRHAGE
    Peters, Nicholas
    Roque, Tara
    Carmody, Brednan
    CRITICAL CARE MEDICINE, 2020, 48
  • [48] Evaluation of andexanet alfa and four-factor prothrombin complex concentrate (4F-PCC) for reversal of rivaroxaban- and apixaban-associated intracranial hemorrhages
    Barra, Megan E.
    Das, Alvin S.
    Hayes, Bryan D.
    Rosenthal, Eric S.
    Rosovsky, Rachel P.
    Fuh, Lanting
    Patel, Aman B.
    Goldstein, Joshua N.
    Roberts, Russel J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (07) : 1637 - 1647
  • [49] PROSPECTIVE EVALUATION OF A FIXED-DOSE 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE PROTOCOL FOR URGENT VITAMIN K ANTAGONIST REVERSAL
    Bitonti, Michael T.
    Rumbarger, Rachel L.
    Absher, Randall K.
    Curran, Lisa M.
    JOURNAL OF EMERGENCY MEDICINE, 2020, 58 (02): : 324 - 329
  • [50] SAFETY OF A 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE (4F-PCC) VERSUS PLASMA FOR VITAMIN K ANTAGONIST REVERSAL: AN INTEGRATED DATA ANALYSIS OF TWO PHASE III CLINICAL TRIALS
    Milling, Truman J.
    Refaai, Majed A.
    Sarode, Ravi
    Lewis, Brandon
    Mangione, Antoinette
    Durn, Billie L.
    Goldstein, Joshua N.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E26 - E26
12345